Natural Product Dietary Supplement Use by Individuals With Rheumatoid Arthritis: A Scoping Review
- 5 July 2018
- journal article
- review article
- Published by Wiley in Arthritis Care & Research
- Vol. 71 (6) , 787-797
Abstract
Objective: Natural product dietary supplements (NDS), defined as non‐mineral, non‐vitamin, ingested, natural product–derived, substances, are the most frequently used complementary and alternative medicine modality in the US, with musculoskeletal disease being the most frequent reason for their use. Because NDS usage is frequently unreported, and patients with RA may be at higher risk for NDS‐related side effects due the underlying nature of the disease and frequent use of complex pharmaceutical regimens, a scoping review of the literature was undertaken to examine population‐based patterns of NDS use for RA self‐management.Methods: Using guidelines for scoping reviews, Allied and Complementary Medicine, the Cumulative Index to Nursing and Allied Health Literature, the Cochrane Library, Embase, Ovid/Medline, and Web of Science databases were searched to identify references presenting primary data related to the prevalence or patterns of use of NDS in RA populations.Results: Twenty‐three studies, which were published between 1980 and 2015 and conducted in 11 countries, met the inclusion criteria. The overall prevalence of NDS use in patients with RA was 47% worldwide and did not differ by geographic region. On average, 47% of patients found NDS to be effective and 13% reported adverse side effects, with only 30% informing their physicians about the use of NDS, which in a majority of cases were used concomitantly with RA pharmaceuticals. Marine oils, glucosamine, vinegar, and chondroitin were among the most commonly reported NDS worldwide.Conclusion: Given the apparent communication gap between patients and providers regarding NDS use and higher potential risks associated with this usage in RA, ongoing surveillance of population‐based practices may help facilitate RA management and direct future NDS research.Keywords
Funding Information
- National Heart, Lung, and Blood Institute (T35HL007479)
- National Center for Complementary and Integrative Health (R34 AT007837)
This publication has 40 references indexed in Scilit:
- Complementary and Alternative Medicine Use in African Americans With Rheumatoid ArthritisArthritis Care & Research, 2013
- Enhancing the scoping study methodology: a large, inter-professional team’s experience with Arksey and O’Malley’s frameworkBMC Medical Research Methodology, 2013
- Integration of complementary and alternative medicine in primary care: What do patients want?Patient Education and Counseling, 2012
- Evidence for the efficacy of complementary and alternative medicines in the management of rheumatoid arthritis: a systematic reviewRheumatology, 2011
- Herbal therapy for treating rheumatoid arthritisCochrane Database of Systematic Reviews, 2011
- Scoping studies: advancing the methodologyImplementation Science, 2010
- Complementary and Alternative Medicine in Rheumatoid Arthritis: No Longer the Last Resort!HSS Journal®: The Musculoskeletal Journal of Hospital for Special Surgery, 2010
- Use of complementary and alternative medicine by rheumatoid arthritis patients in KoreaClinical Rheumatology, 2007
- Scoping studies: towards a methodological frameworkInternational Journal of Social Research Methodology, 2005
- Use of complementary and alternative medicine by arthritis patients in a university hospital clinic serving rheumatology patients in KoreaRheumatology International, 2003